Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191))

J Infect. 2022 Apr;84(4):e10-e12. doi: 10.1016/j.jinf.2022.01.035. Epub 2022 Feb 1.
No abstract available

Publication types

  • Clinical Study
  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • DNA, Viral
  • Guanine / analogs & derivatives
  • Hepatitis B Surface Antigens*
  • Hepatitis B e Antigens*
  • Hepatitis B virus / genetics
  • Humans
  • RNA
  • Treatment Outcome

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • entecavir
  • Guanine
  • RNA